Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 12, 2011, Pages 1869-1873

  Passweg, Jakob R ^a   Zhang, Mei Jie ^b   Rocha, Vanderson ^c   Kan, Fangyu ^d   Champlin, Richard E ^e   Isola, Luis M ^f   Gee, Adrian P ^g   Gibson, John ^h   Laughlin, Mary J ⁱ   Lazarus, Hillard M ^j   Loren, Alison ^k   Marks, David I ^l   Gratwohl, Alois ^a   Eapen, Mary ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c SAINT LOUIS HOSPITAL   (France)

^d NATIONAL MARROW DONOR PROGRAM   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f MOUNT SINAI MEDICAL CENTER   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^j UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^k HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^l UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

Leukemias; Reduced intensity conditioning regimen; Unrelated donor transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; DONOR; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOINCOMPATIBILITY; HLA MATCHING; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REDUCED INTENSITY CONDITIONING; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS; YOUNG ADULT;

EID: 81255172445     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.07.008     Document Type: Article

References (15)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
2. Ljungman P., Urbano-Ispizua A., Cavazzana-Calvo M., et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006, 37:439-449. for the European Group for Blood and Marrow.
3. Or R., Shapira M.Y., Resnick I., et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood 2003, 101:441-445.
4. Storb R.F., Champlin R., Riddell S.R., Murata M., Bryant S., Warren E.H. Non-myeloablative transplants for malignant disease. Hematology Am Soc Hematol Educ Program 2001, 375-391.
5. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
6. Kollman C., Howe C.W.S., Anasetti C., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001, 98:2043-2051.
7. Bacigalupo A., Ballen K., Rizzo J.D., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
8. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-identical sibling donors. Transplantation 1974, 18:295-304.
9. Flowers M.E., Kansu E., Sullivan K.M. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999, 13:1091-1112.
10. Klein J.P., Moeschberger M.L. Survival Analysis: Statistical Methods for Censored and Truncated Data 2003, Springer-Verlag, New York.
11. Cox D.R. Regression models and life tables. J R Stat Soc B 1972, 34:187-200.
12. Andersen P.K., Klein J.P., Zhang M.J. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med 1999, 18:1489-1500.
13. Soiffer R.J., Le Rademacher J., Ho V., et al. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood 2011, 117:6963-6970.
14. Randolph S.S., Gooley T.A., Warren E.H., Appelbaum F.R., Riddell S.R. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004, 103:347-352.
15. Stern M., Brand R., de Witte T., et al. Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant 2008, 8:2149-2157.